lets look at CST96m shares on issue with a market cap of $260...

lets look at CST

96m shares on issue with a market cap of $260 m

as at June 30....had revenues for the FY of $10.5m

and had positive cash flows of $196k in the June quarter.

with $12m in the bank.

Oh yeah...its taking time allright.

funny how CST said in April QFT would receive FDA approval by 30th June

its August.

having delays are we?????

not very transparent in informing shareholders as to why there is a delay.


$260 MILLION market cap


sure some blue sky built into that.